TJ347B - Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia - Google Patents
Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasiaInfo
- Publication number
- TJ347B TJ347B TJ97000493A TJ97000493A TJ347B TJ 347 B TJ347 B TJ 347B TJ 97000493 A TJ97000493 A TJ 97000493A TJ 97000493 A TJ97000493 A TJ 97000493A TJ 347 B TJ347 B TJ 347B
- Authority
- TJ
- Tajikistan
- Prior art keywords
- proliteration
- cryptophicin
- inhibit
- cells
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/400,057 US6013626A (en) | 1993-12-21 | 1995-03-07 | Cryptophycins from synthesis |
US08/482,141 US5952298A (en) | 1993-12-21 | 1995-06-07 | Cryptophycins |
PCT/US1996/003246 WO1996040184A1 (en) | 1995-03-07 | 1996-03-07 | New cryptophycins from synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
TJ347B true TJ347B (en) | 2002-10-06 |
Family
ID=27016884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TJ97000493A TJ347B (en) | 1995-03-07 | 1996-03-07 | Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0830136B1 (en) |
JP (1) | JP4181632B2 (en) |
CN (1) | CN1165337C (en) |
AP (1) | AP737A (en) |
AT (1) | ATE279935T1 (en) |
AU (1) | AU723652B2 (en) |
BG (1) | BG63289B1 (en) |
CZ (1) | CZ278197A3 (en) |
DE (1) | DE69633667T2 (en) |
ES (1) | ES2230561T3 (en) |
FI (1) | FI973591A0 (en) |
GE (1) | GEP20002206B (en) |
HK (1) | HK1009747A1 (en) |
HU (1) | HU225041B1 (en) |
MD (1) | MD2196B2 (en) |
NO (1) | NO326685B1 (en) |
NZ (1) | NZ305571A (en) |
OA (1) | OA10614A (en) |
PL (1) | PL185949B1 (en) |
RO (1) | RO118931B1 (en) |
SK (1) | SK119997A3 (en) |
TJ (1) | TJ347B (en) |
WO (1) | WO1996040184A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2246117A1 (en) * | 1995-08-30 | 1997-03-06 | University Of Hawai'i | Cryptophycins from aberrant biosynthesis |
US6680311B1 (en) | 1996-08-30 | 2004-01-20 | Eli Lilly And Company | Cryptophycin compounds |
EA001913B1 (en) * | 1996-08-30 | 2001-10-22 | Эли Лилли Энд Компани | Pharmaceutical compounds |
AU4233997A (en) * | 1996-08-30 | 1998-03-19 | Eli Lilly And Company | Process for preparing pharmaceutical compounds |
EP0956295A1 (en) * | 1996-09-06 | 1999-11-17 | Eli Lilly And Company | Process to prepare pharmaceutical compounds |
WO1998009601A2 (en) * | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Process to prepare pharmaceutical compounds |
AU4335297A (en) * | 1996-09-06 | 1998-03-26 | Eli Lilly And Company | Process and novel intermediates |
JP2001513775A (en) * | 1997-02-26 | 2001-09-04 | イーライ・リリー・アンド・カンパニー | Tripeptide and tetrapeptide pharmaceutical compounds |
US6143909A (en) * | 1997-02-26 | 2000-11-07 | Eli Lilly And Company | Selective epoxidation process for preparing pharmaceutical compounds |
EP0870510A3 (en) * | 1997-04-11 | 1999-09-15 | Eli Lilly And Company | Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents |
EP0870501A1 (en) * | 1997-04-11 | 1998-10-14 | Eli Lilly And Company | Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections |
EP0870506A1 (en) * | 1997-04-11 | 1998-10-14 | Eli Lilly And Company | Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer |
CA2347246A1 (en) * | 1998-10-16 | 2000-04-27 | James Abraham Aikins | Stereoselective process for producing cryptophycins |
US6103913A (en) * | 1998-10-16 | 2000-08-15 | Eli Lilly And Company | Process for preparing enollactone derivatives |
US6376230B1 (en) | 1998-10-16 | 2002-04-23 | Eli Lilly And Company | Stereoselective process for producing intermediates of cryptophycins |
WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
US6372936B1 (en) * | 1999-06-09 | 2002-04-16 | Eli Lilly And Company | Optical resolution of aminoisobobutyric acid |
FR2947269B1 (en) | 2009-06-29 | 2013-01-18 | Sanofi Aventis | NEW ANTICANCER COMPOUNDS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
WO1995017093A1 (en) * | 1993-12-21 | 1995-06-29 | University Of Hawaii | New cryptophycins |
-
1996
- 1996-03-07 PL PL96322507A patent/PL185949B1/en unknown
- 1996-03-07 CN CNB96193140XA patent/CN1165337C/en not_active Expired - Lifetime
- 1996-03-07 JP JP50044097A patent/JP4181632B2/en not_active Expired - Lifetime
- 1996-03-07 HU HU9801880A patent/HU225041B1/en not_active IP Right Cessation
- 1996-03-07 WO PCT/US1996/003246 patent/WO1996040184A1/en active IP Right Grant
- 1996-03-07 MD MD97-0313A patent/MD2196B2/en unknown
- 1996-03-07 AU AU53603/96A patent/AU723652B2/en not_active Expired
- 1996-03-07 TJ TJ97000493A patent/TJ347B/en unknown
- 1996-03-07 DE DE69633667T patent/DE69633667T2/en not_active Expired - Lifetime
- 1996-03-07 AT AT96910399T patent/ATE279935T1/en not_active IP Right Cessation
- 1996-03-07 AP APAP/P/1997/001069A patent/AP737A/en active
- 1996-03-07 SK SK1199-97A patent/SK119997A3/en unknown
- 1996-03-07 EP EP96910399A patent/EP0830136B1/en not_active Expired - Lifetime
- 1996-03-07 CZ CZ972781A patent/CZ278197A3/en unknown
- 1996-03-07 GE GEAP19963909A patent/GEP20002206B/en unknown
- 1996-03-07 NZ NZ305571A patent/NZ305571A/en not_active IP Right Cessation
- 1996-03-07 RO RO97-01693A patent/RO118931B1/en unknown
- 1996-03-07 ES ES96910399T patent/ES2230561T3/en not_active Expired - Lifetime
-
1997
- 1997-09-03 FI FI973591A patent/FI973591A0/en not_active Application Discontinuation
- 1997-09-04 BG BG101875A patent/BG63289B1/en unknown
- 1997-09-05 NO NO19974105A patent/NO326685B1/en not_active IP Right Cessation
- 1997-09-05 OA OA70070A patent/OA10614A/en unknown
-
1998
- 1998-09-17 HK HK98110673A patent/HK1009747A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TJ347B (en) | Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia | |
PL322494A1 (en) | Compounds and compositions intended to provide active substances | |
EP0871494A4 (en) | Compositions and methods for treating tumor cells | |
AU2113295A (en) | Novel compositions and methods for water treatment | |
AU5439996A (en) | Compositions and methods for treating pain | |
ZA96740B (en) | Skin treatment composition | |
EP0784598A4 (en) | Treatment of nutrient-rich water | |
GB9310241D0 (en) | Cosmetic treatment of substrates | |
IL108020A0 (en) | Treatment of lignocellulosic biomass | |
AU1128297A (en) | Composition for treating pain | |
EP0735894A4 (en) | Composition and methods to improve neural outcome | |
GB9208921D0 (en) | Electrochemical treatment of surfaces | |
GB9601978D0 (en) | Application of materials to substrates | |
IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
AU7951591A (en) | Methods for treating inflammation and compounds and compositions suitable for use therein | |
GB9507297D0 (en) | New composition of matter | |
AU3477093A (en) | 17beta -hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones useful to treat baldness | |
GB9517111D0 (en) | Surface-coating composition and method of application | |
EP0903080A4 (en) | Red tide eliminating composition and method for getting rid of red tide | |
EP0840605A4 (en) | Compounds useful in the treatment of neurofibromatosis | |
GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
IL124419A0 (en) | Composition for treating pain | |
AU7366591A (en) | Method and composition for water treatment | |
LT95119A (en) | Composition of whisky | |
AU4652393A (en) | Plant treating composition and methods of making and using same |